Literature DB >> 28387666

Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner.

Samantha L Gardener1,2, Stephanie R Rainey-Smith1,2, Hamid R Sohrabi1,2,3, Michael Weinborn1,2,4, Giuseppe Verdile1,2,5, W M A D Binosha Fernando1,2, Yen Ying Lim6, Karra Harrington6,7, Samantha Burnham8, Kevin Taddei1,2, Colin L Masters6, Stuart L Macaulay9, Christopher C Rowe10, David Ames11,12, Paul Maruff13, Ralph N Martins1,2,3.   

Abstract

Evidence suggests that a diet low in carbohydrates can impact on cognitive performance among those with Alzheimer's disease (AD). However, there is a lack of data assessing this relationship among cognitively normal (CN) older adults at increased future risk of developing AD due to carriage of the apolipoprotein E (APOE) ɛ4 allele. We assessed the cross-sectional association between carbohydrate intake, cognitive performance, and cerebral amyloid-β (Aβ) load in CN older adults, genotyped for APOEɛ4 allele carrier status. Greater carbohydrate intake was associated with poorer performance in verbal memory in APOEɛ4 allele non-carriers, and poorer performance in attention in APOEɛ4 allele carriers. There were no associations between carbohydrate intake and cerebral Aβ load. These results provide support to the idea that decreasing carbohydrate intake may offer neurocognitive benefits, with specific cognitive domains affected in an APOE genotype-dependent manner. These findings warrant further investigation utilizing a longitudinal study design.

Entities:  

Keywords:  Amyloid load; PiB PET; apolipoprotein E; attention; carbohydrates; cognition; verbal memory

Mesh:

Substances:

Year:  2017        PMID: 28387666     DOI: 10.3233/JAD-161158

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  6 in total

1.  The use of the ketogenic diet in the treatment of psychiatric disorders.

Authors:  Erika E Tillery; Katie D Ellis; Tiffaney B Threatt; Hannah A Reyes; Christopher S Plummer; Logan R Barney
Journal:  Ment Health Clin       Date:  2021-05-12

Review 2.  Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.

Authors:  Ralph N Martins; Victor Villemagne; Hamid R Sohrabi; Pratishtha Chatterjee; Tejal M Shah; Giuseppe Verdile; Paul Fraser; Kevin Taddei; Veer B Gupta; Stephanie R Rainey-Smith; Eugene Hone; Steve Pedrini; Wei Ling Lim; Ian Martins; Shaun Frost; Sunil Gupta; Sid O'Bryant; Alan Rembach; David Ames; Kathryn Ellis; Stephanie J Fuller; Belinda Brown; Samantha L Gardener; Binosha Fernando; Prashant Bharadwaj; Samantha Burnham; Simon M Laws; Anna M Barron; Kathryn Goozee; Eka J Wahjoepramono; Prita R Asih; James D Doecke; Olivier Salvado; Ashley I Bush; Christopher C Rowe; Samuel E Gandy; Colin L Masters
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Ketogenic Ratio Determines Metabolic Effects of Macronutrients and Prevents Interpretive Bias.

Authors:  Tanya Zilberter; Yuri Zilberter
Journal:  Front Nutr       Date:  2018-08-30

4.  Impact of Apolipoprotein E gene polymorphism during normal and pathological conditions of the brain across the lifespan.

Authors:  Diego Iacono; Gloria C Feltis
Journal:  Aging (Albany NY)       Date:  2019-01-24       Impact factor: 5.682

5.  High Glycemic Load Is Associated with Cognitive Decline in Apolipoprotein E ε4 Allele Carriers.

Authors:  Mélissa Gentreau; Michel Raymond; Virginie Chuy; Cécilia Samieri; Catherine Féart; Claire Berticat; Sylvaine Artero
Journal:  Nutrients       Date:  2020-11-25       Impact factor: 5.717

6.  Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's Disease.

Authors:  Christopher Fowler; Stephanie R Rainey-Smith; Sabine Bird; Julia Bomke; Pierrick Bourgeat; Belinda M Brown; Samantha C Burnham; Ashley I Bush; Carolyn Chadunow; Steven Collins; James Doecke; Vincent Doré; Kathryn A Ellis; Lis Evered; Amir Fazlollahi; Jurgen Fripp; Samantha L Gardener; Simon Gibson; Robert Grenfell; Elise Harrison; Richard Head; Liang Jin; Adrian Kamer; Fiona Lamb; Nicola T Lautenschlager; Simon M Laws; Qiao-Xin Li; Lucy Lim; Yen Ying Lim; Andrea Louey; S Lance Macaulay; Lucy Mackintosh; Ralph N Martins; Paul Maruff; Colin L Masters; Simon McBride; Lidija Milicic; Madeline Peretti; Kelly Pertile; Tenielle Porter; Morgan Radler; Alan Rembach; Joanne Robertson; Mark Rodrigues; Christopher C Rowe; Rebecca Rumble; Olivier Salvado; Greg Savage; Brendan Silbert; Magdalene Soh; Hamid R Sohrabi; Kevin Taddei; Tania Taddei; Christine Thai; Brett Trounson; Regan Tyrrell; Michael Vacher; Shiji Varghese; Victor L Villemagne; Michael Weinborn; Michael Woodward; Ying Xia; David Ames
Journal:  J Alzheimers Dis Rep       Date:  2021-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.